Alumni Ventures Group
Alumni Ventures Group is a venture capital firm based in Manchester, New Hampshire, with offices across North America. It provides access to venture investing for individual accredited investors, particularly alumni networks, by offering diversified portfolios of venture opportunities and allowing members to invest alongside fellow alumni in ventures led by peers. The firm backs early-stage and later-stage opportunities across technology, consumer, healthcare, financial services, and other sectors, with a sector- and geography-agnostic approach. It typically invests between $10,000 and $3 million per deal and emphasizes the involvement of alumni connections and an institutional lead investor in opportunities. Alumni Ventures also offers focused funds to broaden participation, enabling accredited investors to access venture portfolios diversified by type, sector, stage, and geography. The model aims to democratize access to venture capital while maintaining rigorous selection standards through alumni networks.
Top Sectors
Top Regions
https://crunchbase.com/organization/***
https://linkedin.com/company/***
https://signal.nfx.com/firms/***
Past deals in Health Diagnostics
Epicore Biosystems
Series B in 2025
Epicore Biosystems, Inc. is a Cambridge, Massachusetts-based company that develops and commercializes a proprietary wearable microfluidic sensing platform designed for athletes. Founded in 2017, the company focuses on analyzing small droplets of sweat directly from the skin to measure a range of health and performance metrics. Its technology allows for non-invasive monitoring of sweat biomarkers, skin health, and physiological states in real-time, facilitating personalized management of hydration, nutrition, and overall health. Epicore's innovative platform is grounded in extensive research in microfluidics and soft materials, aiming to enhance athletic performance and health management through accessible and cost-effective solutions.
Salvo Health
Seed Round in 2025
Salvo Health is a specialty care provider operating an app-based virtual clinic focused on managing chronic gut conditions. The company improves access to advanced healthcare by employing its proprietary Whole Self Science model, which considers overall health and contributing factors beyond the gut to pinpoint underlying causes and offer individualized, ongoing treatment strategies for patients with chronic gastrointestinal issues.
MetaSight Diagnostics
Series A in 2024
MetaSight Diagnostics, a health technology company, is on a mission to develop affordable and precise liquid biopsy diagnostics for the early detection of a wide range of chronic and acute diseases by leveraging proprietary mass spectrometry technologies (metabolomics, lipidomics, and proteomics).
Canid
Series A in 2024
Canid is a healthcare technology company that focuses on pediatric vaccination workflows. It provides a healthcare dashboard and process tool to simplify vaccination record management, automate vaccine workflow, and oversee vaccine inventory. The platform includes a scanning system that eliminates manual data entry by capturing vaccine information and uploading it to state immunization registries, reducing administrative tasks for pediatric practitioners. It also offers administrative consulting and helps secure vaccine margins, supporting efficient practice operations for clinicians while giving state officials clearer oversight of vaccination programs.
Centaur Labs
Series B in 2024
Centaur Labs provides a platform for expert data annotation services, specializing in medical, scientific, and other complex datasets. It leverages a global network of tens of thousands of students and professionals to deliver accurate and scalable solutions.
Q Bio
Venture Round in 2024
Q Bio, Inc., established in 2015, develops a comprehensive health assessment platform that combines advanced non-invasive imaging, genetic testing, vital signs, and medical history to provide a snapshot of an individual's health. The company's flagship product, Q BioVault, aggregates and summarizes an individual's entire medical history, identifying and tracking significant health changes. Q Bio's interdisciplinary team, based in San Carlos, California, comprises experts in applied math, computational physics, electrical engineering, genetics, and radiology. Backed by prominent venture capital firms, the company aims to empower healthcare professionals with proactive, data-driven insights to improve patient outcomes.
Magnetic Insight
Series B in 2024
Magnetic Insight, Inc. is a company specializing in magnetic particle imaging (MPI), an innovative imaging modality that detects iron oxide nanoparticle tracers through time-varying magnetic fields. Founded in 2012 and headquartered in Alameda, California, the company offers several key products, including the MOMENTUM imager, a pre-clinical MPI solution designed to produce high-quality images using advanced magnetic field gradients and proprietary reconstruction processes. Additionally, Magnetic Insight develops VivoTrax, a nanoparticle for cell tracking and as a blood pool agent, and Hyper, an add-on module for the MOMENTUM system that facilitates targeted magnetic hyperthermia treatment. The company's technology enables real-time monitoring of biological events, making significant strides in areas such as quantitative cell tracking, imaging of vascular function, and research into regenerative medicine and CAR-T cell therapies.
Hopscotch Primary Care
Series C in 2024
Hopscotch Primary Care is a healthcare company focused on transforming rural healthcare through data-driven, team-based care that expands access and improves quality for patients in rural communities. The organization delivers tailored quality care via a collaborative model and provides resources and support for patients inside and outside clinics, enabling clinicians to offer the right care and continuity of service.
Shape
Seed Round in 2024
Shape specializes in developing a 3D body scanning system that allows users to digitally measure and visualize their body composition in photorealistic detail. Utilizing advanced technologies such as artificial intelligence and computer vision, Shape provides accurate assessments of body metrics that traditional methods cannot capture, including regional volume and changes in body composition. The system offers personalized insights and guidance based on individual user data, helping users track fat loss and muscle gains in an engaging manner. By delivering fast and gamified feedback, Shape aims to transform how individuals approach their health and fitness goals, enhancing motivation and progress tracking.
ParcelBio
Seed Round in 2024
ParcelBio is a biotechnology company specializing in the development of a novel, programmable method for safely and precisely delivering messenger RNA (mRNA) to diverse cell types within the body. Their technology aims to create targeted, potent, and durable RNA therapeutics, with the potential to treat a wide range of diseases, including cancer, genetic disorders, and infectious diseases.
Alvee
Seed Round in 2024
Alvee offers an AI-driven tool for healthcare providers and payers. It assesses patients' health equity status by considering social determinants of health, chronic conditions, demographics, and health inequity risks. This enables better patient care and helps meet data stratification quality reporting requirements.
Epicore Biosystems
Venture Round in 2024
Epicore Biosystems, Inc. is a Cambridge, Massachusetts-based company that develops and commercializes a proprietary wearable microfluidic sensing platform designed for athletes. Founded in 2017, the company focuses on analyzing small droplets of sweat directly from the skin to measure a range of health and performance metrics. Its technology allows for non-invasive monitoring of sweat biomarkers, skin health, and physiological states in real-time, facilitating personalized management of hydration, nutrition, and overall health. Epicore's innovative platform is grounded in extensive research in microfluidics and soft materials, aiming to enhance athletic performance and health management through accessible and cost-effective solutions.
Piction Health
Seed Round in 2024
Piction Health is a company focused on enhancing access to dermatology care for patients experiencing skin, hair, or nail issues. The company offers a dermatology care application that allows patients to receive expert consultations from dermatologists within two days, including a diagnosis and personalized care plan. By leveraging artificial intelligence, Piction Health streamlines the diagnostic process for both patients and primary care providers, enabling quicker assessments of complex skin conditions. The application provides immediate second opinions, allowing primary care providers to efficiently address challenging skin diseases, thereby saving time and reducing costs associated with unnecessary repeat visits and ineffective treatments. Piction Health aims to ensure that high-quality dermatological care is accessible from the comfort of home, ultimately improving patient outcomes.
Earli
Series A in 2024
Earli is a biotechnology company focused on advancing cancer detection and treatment through innovative technology. The company specializes in developing devices that utilize a novel gene therapy approach known as Synthetic Biopsy. This method compels cancer cells to produce synthetic biomarkers, which are not naturally occurring in the human body. These biomarkers can then be detected in bodily fluids such as blood, urine, or breath, allowing for early identification of cancer. By facilitating the early detection of homogeneous tumors, Earli aims to significantly improve the chances of successful treatment and personalize therapy options for patients. Additionally, the technology is designed to be visible during imaging procedures such as PET scans, enhancing the monitoring of cancer progression and treatment efficacy.
Emm
Seed Round in 2023
Emm is a company focused on consumer health technology, developing tools to help individuals manage their health on their terms. It is building a menstrual cup with integrated biosensors designed to track biometric data and deliver personalized insights about menstrual health. The device aims to redefine period experiences by providing actionable information that helps users understand their health through technology and expert knowledge.
Ellipsis Health
Series A in 2023
Founded in 2013, Ellipsis Health is a technology company that uses artificial intelligence to improve behavioral health. It analyzes patient speech and clinical data to predict health outcomes and provide real-time assessments for conditions like depression.
Canid
Seed Round in 2023
Canid is a healthcare technology company that focuses on pediatric vaccination workflows. It provides a healthcare dashboard and process tool to simplify vaccination record management, automate vaccine workflow, and oversee vaccine inventory. The platform includes a scanning system that eliminates manual data entry by capturing vaccine information and uploading it to state immunization registries, reducing administrative tasks for pediatric practitioners. It also offers administrative consulting and helps secure vaccine margins, supporting efficient practice operations for clinicians while giving state officials clearer oversight of vaccination programs.
PulzAid
Pre Seed Round in 2023
PulzAid is a managed marketplace focused on providing healthcare services to injured workers. It facilitates access to telehealth, mobile imaging, specialists, and diagnostic services through its specialized software and established relationships with orthopedic surgeons and occupational medicine doctors. By offering on-demand video consultations, in-person nurse visits, lab testing, and prescription services, PulzAid aims to expedite the treatment process for employees, enabling them to return to work more quickly and in better health. The company's approach not only addresses workplace injuries but also seeks to reduce associated costs and liabilities for employers, particularly in managing workers' compensation claims.
3X Genetics
Pre Seed Round in 2023
3X Genetics is a company focused on developing medical screening solutions aimed at identifying genetic disorders, particularly in infants and children. The company has created innovative technologies that allow for proactive screening of the population for conditions such as myotonic dystrophy and other trinucleotide repeat issues associated with progressive muscle weakness. By enabling healthcare professionals to detect these genetic disorders early, 3X Genetics plays a crucial role in preventing the birth of children affected by serious genetic diseases.
MedScout
Seed Round in 2023
MedScout is a revenue acceleration platform tailored for medical device and diagnostic companies. It offers a sales enablement software that integrates medical claims intelligence from both public and private payors, providing a user-friendly interface specifically designed for sales professionals and leaders. The platform delivers immediate insights into the addressable market within existing territories and facilitates understanding of market dynamics. By supplying comprehensive information on patient demographics, procedure volumes, referral patterns, and payment data, MedScout empowers its clients to optimize their sales strategies and enhance operational productivity, ultimately driving growth in the life sciences sector.
Train Fitness
Seed Round in 2023
Train Fitness specializes in a workout tracking platform that utilizes artificial intelligence to automatically detect exercise sets and repetitions during strength training. By analyzing motion data from the Apple Watch, Train provides users with expertise-level insights into their workouts. This technology enables real-time coaching, allowing fitness enthusiasts to identify weaknesses, monitor their progress, and enhance their performance. The company's focus on automatic exercise detection positions it as a valuable resource for individuals looking to improve their fitness regimen.
Pathfinder Health
Seed Round in 2023
Pathfinder Health is a company that focuses on supporting the development of children aged 0-5 through an evidence-based clinical tool. This tool aids in monitoring child development milestones and offers guidance on how caregivers can effectively engage with children at various stages of their growth. By facilitating communication with healthcare professionals, the app promotes earlier diagnoses of developmental concerns. It also provides users with access to a wealth of resources, including evidence-based activities, articles, parenting tips, and local early intervention services. Through its innovative approach, Pathfinder Health empowers parents and caregivers to track their child's progress and identify potential developmental issues promptly.
Rensair
Series A in 2023
Rensair develops portable hospital-grade air purifiers designed for hospitals, schools and care homes, trusted by businesses worldwide. Its purification technology combines HEPA-grade filtration with ozone-free ultraviolet light to clean the air and reduce airborne contaminants, creating healthier indoor environments while aiming to lower emissions and energy use.
Axoft
Seed Round in 2022
Axoft develops implantable, bioinspired electronics that enable long-term communication with the nervous system to improve clinical outcomes and overall health. The company creates ultra-flexible plastic mesh implants housing multiple sensors that closely match brain tissue mechanics, aiming to reduce tissue response and enable precise monitoring and intervention for neurodegenerative conditions. By enhancing brain–machine communication, Axoft seeks to provide more effective treatments for patients with Parkinson's disease and related disorders, supporting tailored therapies and better patient outcomes.
Koala Health
Series A in 2022
Founded in 2021, Koala Health simplifies pet care by providing medications and health products through its digital platform. It offers features such as prescription management, date-and-time-based packaging, and free delivery.
PathSpot
Series A in 2022
PathSpot Technologies, Inc., established in 2017 and headquartered in New York City, specializes in food safety solutions. The company develops and manufactures a unique system that uses a proprietary algorithm to analyze fluorescent light, enabling it to scan employees' hands and detect pathogens that cause food-borne illnesses. This technology helps restaurants and their customers mitigate the risk of food-borne illnesses by providing instant, invisible signs of harmful bacteria and viruses.
Nanopath
Series A in 2022
Nanopath is a molecular diagnostics company that develops innovative platforms for rapid disease diagnosis. Its technology enables point-of-care testing, eliminating the need for nucleic acid amplification and supporting multiplexed detection. This allows patients and healthcare providers to access accurate diagnostic results within standard office visits, improving healthcare outcomes.
Magnetic Insight
Series B in 2022
Magnetic Insight, Inc. is a company specializing in magnetic particle imaging (MPI), an innovative imaging modality that detects iron oxide nanoparticle tracers through time-varying magnetic fields. Founded in 2012 and headquartered in Alameda, California, the company offers several key products, including the MOMENTUM imager, a pre-clinical MPI solution designed to produce high-quality images using advanced magnetic field gradients and proprietary reconstruction processes. Additionally, Magnetic Insight develops VivoTrax, a nanoparticle for cell tracking and as a blood pool agent, and Hyper, an add-on module for the MOMENTUM system that facilitates targeted magnetic hyperthermia treatment. The company's technology enables real-time monitoring of biological events, making significant strides in areas such as quantitative cell tracking, imaging of vascular function, and research into regenerative medicine and CAR-T cell therapies.
Swing Therapeutics
Series A in 2022
Swing develops safe and effective digital therapeutics for chronic conditions, partnering with top researchers to create evidence-based treatments. Their solutions empower patients to manage their illnesses, improving health outcomes.
Quadrant Health
Pre Seed Round in 2022
Quadrant Health is a health technology company that provides a cloud-based analytics platform for healthcare providers to analyze electronic health records and patient messaging data in real time. The platform uses machine learning to identify potential health risks and to predict infections, injuries, and other harms before symptoms appear, enabling proactive patient care and support for preventive medicine.
Oobli
Series B in 2022
Oobli develops healthy, low-calorie protein sweeteners derived from exotic plants. These rare compounds offer great taste without affecting blood sugar levels or gut microbiome. The company has secured regulatory approvals such as FDA 'no questions' letters and GRAS status for multiple proteins.
NeuraLight
Series A in 2022
NeuraLight is a venture-backed company dedicated to improving the lives of billions affected by neurological disorders. It develops a digital neurology platform that uses smartphone or webcam technology to accurately assess and monitor patients, enabling better evaluation and care.
Legacy
Series B in 2022
Legacy is a company focused on transforming male fertility through innovative testing and preservation solutions. Founded by healthcare and fertility experts, Legacy provides home-based kits that allow men to analyze, improve, and preserve their sperm without the need to visit a clinic. Their offerings include sperm analysis and cryogenic storage options, facilitating the preservation of fertility for clients in a straightforward and accessible manner. The company collaborates with leading hospitals, fertility clinics, and progressive employers to ensure high-quality services. Legacy has garnered recognition through various awards, including victories at TechCrunch Disrupt and MassChallenge Boston, and has attracted investment from notable firms such as Bain Capital Ventures and Section 32.
Rensair
Series A in 2022
Rensair develops portable hospital-grade air purifiers designed for hospitals, schools and care homes, trusted by businesses worldwide. Its purification technology combines HEPA-grade filtration with ozone-free ultraviolet light to clean the air and reduce airborne contaminants, creating healthier indoor environments while aiming to lower emissions and energy use.
Health Hero
Seed Round in 2022
Health Hero, Inc. is a wellness technology company that specializes in developing a custom wellness platform aimed at enhancing employee well-being across various industries globally. Founded in 2014 and headquartered in Tampa, Florida, the company offers a range of wellness options, including health risk assessments, cultural assessments, and biometric screenings, which can be accessed through mobile devices and computers. Health Hero's platform integrates gamification elements to engage employees by allowing them to earn points, badges, and rewards for completing tasks and reaching milestones. With a user reach exceeding five million and support for over 14,000 companies and communities, Health Hero effectively stores more than five billion health data points, positioning itself as a leader in the well-being sector.
Epicore Biosystems
Series A in 2022
Epicore Biosystems, Inc. is a Cambridge, Massachusetts-based company that develops and commercializes a proprietary wearable microfluidic sensing platform designed for athletes. Founded in 2017, the company focuses on analyzing small droplets of sweat directly from the skin to measure a range of health and performance metrics. Its technology allows for non-invasive monitoring of sweat biomarkers, skin health, and physiological states in real-time, facilitating personalized management of hydration, nutrition, and overall health. Epicore's innovative platform is grounded in extensive research in microfluidics and soft materials, aiming to enhance athletic performance and health management through accessible and cost-effective solutions.
Iterative Scopes
Series B in 2022
Iterative Scopes, Inc. is a Boston-based company established in 2017 that specializes in developing machine learning-powered diagnostic tools aimed at assisting gastroenterologists in the prevention of colon cancer. The company focuses on providing innovative solutions for physicians and life sciences professionals within the colorectal cancer and inflammatory bowel disease sectors. By leveraging advanced technology, Iterative Scopes aims to enhance diagnostic accuracy and improve patient outcomes in these critical areas of healthcare.
The Pact
Seed Round in 2022
Pact is a company that specializes in muscle scanning technology, offering a system designed to assess muscle condition and develop personalized recovery solutions for athletes. The company has created a full-feedback app connected to a massager that not only scans muscles but also tailors warm-up and recovery routines based on individual needs. This adaptive approach allows athletes to optimize their recovery process, addressing specific injuries and enhancing overall performance. By combining innovative technology with a focus on personalized care, Pact aims to support athletes in achieving their long-term fitness goals.
Kinsa
Series B in 2021
Kinsa, Inc., established in 2012 and headquartered in San Francisco, develops smart thermometers that connect to both Android and iOS devices. These thermometers facilitate communication with individuals who are ill, providing them with care information and enabling data collection to map and track health trends in real-time, thereby aiding in disease spread prevention.
Gordy Health
Convertible Note in 2021
Gordy Health is a virtual care provider based in Pasadena, California, founded in 2021. The company specializes in blood pressure management to reduce patients' risk of heart attack, stroke, and kidney failure. Gordy Health offers a healthcare platform that allows users to manage their blood pressure from home, with features including direct access to heart specialists, easy-to-schedule virtual appointments, real-time diagnostics, prescription delivery, and ongoing monitoring and medication adjustments. The goal is to prevent complications from high blood pressure, helping patients achieve healthier lives and increased longevity.
Olaris
Series B in 2021
Founded in 2013, Olaris is dedicated to transforming disease diagnosis and treatment. Utilizing its CEREBRO platform, which integrates metabolomics and machine learning, the company discovers and develops precision diagnostics under its myOLARIS™ brand.
GritWell
Seed Round in 2021
GritWell Ltd is a digital health platform that specializes in addressing chronic health conditions through a holistic approach. Founded in 2018 and based in San Francisco, the company connects patients with a variety of health professionals, including nutritionists, health coaches, and naturopathic doctors. GritWell's platform facilitates secure video consultations, direct messaging, and online scheduling, allowing for personalized treatment plans and credible advice tailored to individual needs. By focusing on root cause treatment rather than mere symptom management, GritWell employs clinically validated symptom assessments to guide patients toward appropriate care while integrating natural treatment options. This innovative approach aims to improve health outcomes by enabling patients to find practitioners who can address the underlying issues of their chronic symptoms, such as insomnia, migraines, and anxiety.
Asto CT
Series B in 2021
Asto CT is a veterinary imaging company that develops X-ray computed tomography systems for horses, enabling safe, weight-bearing 3D imaging to diagnose and monitor conditions such as lameness, distal limb disease, fractures, and tooth or sinus problems. Its Equina solution provides rapid 3D scans of the lower limbs, head, and neck in standing horses without general anesthesia, supporting early detection and improved treatment planning for Thoroughbreds, other sport and recreation horses, and older animals. The company emphasizes high-quality imaging, ease of use, and integration of advanced robotics with fan-beam CT technology to enhance diagnostic capability and veterinary care. Founded in 2015 and based in Madison, Wisconsin, Asto CT aims to improve horse welfare by enabling safer, more accurate assessment while minimizing anesthesia risks.
Moons
Series A in 2021
Founded in 2019, Moons specializes in orthodontic solutions, offering transparent dental aligners tailored to each patient's needs. The company provides direct-to-consumer products and online dental services in Mexico and Colombia.
SHINE
Series C in 2021
SHINE develops and deploys fusion-based technology to produce medical isotopes and neutron sources. Its processes generate molybdenum-99, a precursor to technetium-99m used in diagnostic imaging, and lutetium-177 for diagnostic and therapeutic use, along with iodine-131 and iodine-125 for thyroid treatment and brachytherapy, and xenon-133 for lung and brain imaging. The company’s systems also provide neutron sources for industrial imaging, radiation-effects testing, and fusion materials research. In addition to medical isotopes, SHINE aims to recycle nuclear waste and advance fusion power as a source of clean energy. The business serves health care and industrial customers worldwide. SHINE is based in Janesville, Wisconsin, with an office in Alkmaar, Netherlands.
Zone7
Convertible Note in 2021
Zone7 is a company that specializes in artificial intelligence-based software designed to predict sports injuries and optimize athletic performance. Founded in 2017 and headquartered in Palo Alto, California, Zone7 collects and analyzes data from various sources, including wearable devices, medical records, and fitness profiles. The software aims to identify injury risks before they occur, enabling coaching staff and medical professionals to make informed decisions regarding training, rest, and work assignments. Zone7's technology is utilized by over 30 professional sports franchises and is also applied in hospitals to monitor the well-being of medical staff. By providing actionable insights, Zone7 enhances the health, potential, and durability of athletes and the elite workforce, ultimately aiming to improve human performance across various fields.
PulseData AI
Series A in 2021
PulseData AI, established in 2015 and headquartered in New York, specializes in healthcare technology. It develops machine learning software that helps healthcare providers identify patients at high risk of adverse, preventable medical outcomes. The company's platform analyzes vast amounts of patient data to predict health trends, enabling care management teams to deliver timely, targeted care, and ultimately reduce preventable illnesses and medical costs.
Scipher Medicine
Series C in 2021
Scipher Medicine develops a molecular technology platform that predicts patient responsiveness to specific drugs in cardiovascular and autoimmune diseases. Its flagship product, PrismRA, identifies rheumatoid arthritis patients unlikely to respond to anti-TNF therapies, enabling alternative treatments. The company aims to transform drug prescription by predicting optimal therapy using simple blood samples.
FULLFILL
Seed Round in 2021
FULLFILL is a digital platform offering virtual health coaching programs designed to prevent and treat chronic conditions. It partners with employers worldwide to improve employee health and reduce medical expenses. The platform offers evidence-based content, daily support from Master Coaches, and engages employees effectively, doubling medical results compared to traditional programs.
Ellipsis Health
Seed Round in 2021
Founded in 2013, Ellipsis Health is a technology company that uses artificial intelligence to improve behavioral health. It analyzes patient speech and clinical data to predict health outcomes and provide real-time assessments for conditions like depression.
SHINE
Venture Round in 2020
SHINE develops and deploys fusion-based technology to produce medical isotopes and neutron sources. Its processes generate molybdenum-99, a precursor to technetium-99m used in diagnostic imaging, and lutetium-177 for diagnostic and therapeutic use, along with iodine-131 and iodine-125 for thyroid treatment and brachytherapy, and xenon-133 for lung and brain imaging. The company’s systems also provide neutron sources for industrial imaging, radiation-effects testing, and fusion materials research. In addition to medical isotopes, SHINE aims to recycle nuclear waste and advance fusion power as a source of clean energy. The business serves health care and industrial customers worldwide. SHINE is based in Janesville, Wisconsin, with an office in Alkmaar, Netherlands.
Brio Systems
Seed Round in 2020
Brio Systems provides a turnkey COVID-19 testing platform for employers, linking laboratories and medical suppliers with workplaces to enable on-site testing. Its platform supports PCR and antibody testing conducted by FDA-certified laboratories, manages logistics for kit distribution and test requisitioning, provides medical oversight, and delivers digital results within about three days of collection. It serves customers across manufacturing, food processing, and other industries, offering a scalable solution that can support up to 50,000 tests daily. Founded in 2017 and based in Boston, Brio Systems focuses on helping employers maintain workforce safety and business continuity through data-driven testing programs.
Oobli
Series A in 2020
Oobli develops healthy, low-calorie protein sweeteners derived from exotic plants. These rare compounds offer great taste without affecting blood sugar levels or gut microbiome. The company has secured regulatory approvals such as FDA 'no questions' letters and GRAS status for multiple proteins.
Brio Systems
Venture Round in 2020
Brio Systems provides a turnkey COVID-19 testing platform for employers, linking laboratories and medical suppliers with workplaces to enable on-site testing. Its platform supports PCR and antibody testing conducted by FDA-certified laboratories, manages logistics for kit distribution and test requisitioning, provides medical oversight, and delivers digital results within about three days of collection. It serves customers across manufacturing, food processing, and other industries, offering a scalable solution that can support up to 50,000 tests daily. Founded in 2017 and based in Boston, Brio Systems focuses on helping employers maintain workforce safety and business continuity through data-driven testing programs.
Oura
Series B in 2020
Oura is a Finnish company that specializes in the development of a smart wellness ring designed to monitor and track various biometric data related to health and well-being. The ring incorporates advanced sensors to measure key metrics such as heart rate, sleep cycles, and activity levels, providing users with insights into their physiological and behavioral responses to sleep, rest, and recovery. This data is accessible through the accompanying Oura application, which enables users to understand their overall health status and make informed lifestyle choices. Oura operates within the health and wellness industry, focusing on enhancing the user's understanding of their body and promoting better health outcomes.
Moons
Seed Round in 2020
Founded in 2019, Moons specializes in orthodontic solutions, offering transparent dental aligners tailored to each patient's needs. The company provides direct-to-consumer products and online dental services in Mexico and Colombia.
Oura
Series B in 2019
Oura is a Finnish company that specializes in the development of a smart wellness ring designed to monitor and track various biometric data related to health and well-being. The ring incorporates advanced sensors to measure key metrics such as heart rate, sleep cycles, and activity levels, providing users with insights into their physiological and behavioral responses to sleep, rest, and recovery. This data is accessible through the accompanying Oura application, which enables users to understand their overall health status and make informed lifestyle choices. Oura operates within the health and wellness industry, focusing on enhancing the user's understanding of their body and promoting better health outcomes.
Asto CT
Venture Round in 2019
Asto CT is a veterinary imaging company that develops X-ray computed tomography systems for horses, enabling safe, weight-bearing 3D imaging to diagnose and monitor conditions such as lameness, distal limb disease, fractures, and tooth or sinus problems. Its Equina solution provides rapid 3D scans of the lower limbs, head, and neck in standing horses without general anesthesia, supporting early detection and improved treatment planning for Thoroughbreds, other sport and recreation horses, and older animals. The company emphasizes high-quality imaging, ease of use, and integration of advanced robotics with fan-beam CT technology to enhance diagnostic capability and veterinary care. Founded in 2015 and based in Madison, Wisconsin, Asto CT aims to improve horse welfare by enabling safer, more accurate assessment while minimizing anesthesia risks.
She's Well
Seed Round in 2019
She's Well provides fertility management services through a subscription model and financing plans, enabling individuals and couples to access fertility testing, IVF, egg freezing, and sperm freezing via a network of leading fertility centers. The company combines financial options with on-demand concierge care to simplify the fertility journey, offering guidance and support to make fertility care more affordable and accessible for people who want to start a family on their own timeline.
Meditrina
Venture Round in 2019
Meditrina, Inc. is a medical device company based in San Jose, California, established in 2016. The company specializes in developing innovative tissue removal solutions specifically designed for intrauterine pathology. Its flagship product, the Aveta System, serves healthcare professionals by providing an all-in-one solution for hysteroscopic diagnostic and therapeutic procedures, such as the removal of polyps and fibroids. The Aveta System is notable for its compact design, which allows for seamless integration into various clinical settings, including offices and operating rooms. It features advanced capabilities such as wide-angle HD hysteroscopy, improved fluid management for better pressure control, and a small insertion diameter coupled with a large working channel, all of which contribute to optimized tissue resection and enhanced procedural efficiency.
Olaris
Venture Round in 2019
Founded in 2013, Olaris is dedicated to transforming disease diagnosis and treatment. Utilizing its CEREBRO platform, which integrates metabolomics and machine learning, the company discovers and develops precision diagnostics under its myOLARIS™ brand.
Vincere Biosciences
Venture Round in 2019
Founded in 2018, Vincere Biosciences is a biotechnology company based in Cambridge, Massachusetts. It specializes in developing small molecule therapeutics for Parkinson's disease using proprietary simulation and artificial intelligence technologies.
E25Bio
Seed Round in 2019
E25Bio Inc. is a biotechnology company based in Cambridge, Massachusetts, founded in 2018, that focuses on developing rapid diagnostic tests for epidemic fever viruses. The company designs paper-based diagnostic systems and kits that facilitate the detection of viruses such as dengue, chikungunya, and Zika. E25Bio's innovative platform enables multiplexed testing that quickly identifies viral antigens during infections, allowing for real-time data reporting through a mobile application. This capability supports epidemiologic predictions and disease mapping, empowering governments and health organizations to respond effectively to outbreaks and manage public health crises. Through its commitment to fast, mobile testing solutions, E25Bio aims to prevent severe health outcomes associated with viral epidemics.
Brave Care
Seed Round in 2019
Brave Care operates pediatric primary and urgent care clinics in Oregon and Texas, offering both emergency and non‑emergency services. The clinics provide treatment for common childhood conditions such as allergies, asthma, ear pain, fever, minor fractures, and urinary tract infections, as well as on‑site laboratory and X‑ray services. A team of pediatric doctors and medical professionals delivers care in a child‑friendly environment designed to reduce the stress and cost associated with emergency medicine. The company also offers a website and mobile app that give parents nationwide access to pediatric advice and support. Founded in 2019 and headquartered in Portland, Oregon, Brave Care focuses on improving access to quality pediatric care.
Legacy
Seed Round in 2019
Legacy is a company focused on transforming male fertility through innovative testing and preservation solutions. Founded by healthcare and fertility experts, Legacy provides home-based kits that allow men to analyze, improve, and preserve their sperm without the need to visit a clinic. Their offerings include sperm analysis and cryogenic storage options, facilitating the preservation of fertility for clients in a straightforward and accessible manner. The company collaborates with leading hospitals, fertility clinics, and progressive employers to ensure high-quality services. Legacy has garnered recognition through various awards, including victories at TechCrunch Disrupt and MassChallenge Boston, and has attracted investment from notable firms such as Bain Capital Ventures and Section 32.
Scipher Medicine
Series B in 2019
Scipher Medicine develops a molecular technology platform that predicts patient responsiveness to specific drugs in cardiovascular and autoimmune diseases. Its flagship product, PrismRA, identifies rheumatoid arthritis patients unlikely to respond to anti-TNF therapies, enabling alternative treatments. The company aims to transform drug prescription by predicting optimal therapy using simple blood samples.
Kindbody
Series A in 2019
Kindbody is a comprehensive fertility clinic network and family-building benefits provider that offers a wide range of services aimed at improving access to healthcare for women. The company provides both virtual and in-person care, including fertility assessments, education, preservation, genetic testing, in vitro fertilization (IVF), donor and surrogacy services, and adoption. By partnering with employers, Kindbody delivers financial, medical, and emotional support to employees pursuing parenthood. The company serves more than 100 employers, covering over 2.4 million lives, while also providing direct fertility care through its network of signature clinics, mobile clinics, and partner clinics across the country. With a focus on affordability and accessibility, Kindbody employs modern technology to deliver holistic health and fertility services.
SleepSpace
Venture Round in 2018
SleepSpace is a pioneering company that has developed the first Sleep Operating System aimed at transforming the smart bedroom with integrated technologies. By harnessing the science of sound, vibration, and light, SleepSpace enhances the sleep experience and offers more accurate sleep measurements than traditional wearables. Its proprietary nearable sensing technology allows smartphones to function as smart beds, providing valuable insights for both users and clinicians. The company's platform enables healthcare professionals to deliver personalized sleep programs while gaining comprehensive data on patients' sleep patterns. SleepSpace has established partnerships with major mattress brands, hotels, and corporate wellness initiatives, underscoring its commitment to improving sleep health. Additionally, the company has received substantial funding through grants from the National Institutes of Health, further validating its innovative approach to sleep improvement.
Mitra Biotech
Series C in 2018
Mitra Biotech, established in 2010, is a biotechnology company based in Woburn, Massachusetts, with a laboratory office in Bengaluru, India. It specializes in personalized cancer treatment, offering a novel functional assay called CANScript. This assay replicates a patient's tumor microenvironment, measures multiple parameters, and converts them into a single score predicting clinical response to selected therapies. Mitra Biotech's technology aids biopharma companies in drug discovery and development, expanding access to personalized medicine and enhancing cancer treatment selection.
Apprentice Health
Seed Round in 2018
Apprentice Health optimizes clinical workflows using real-time location systems, ambient sensors, and AI. Its platform enhances patient scheduling, room utilization, and equipment tracking, reducing wait times and improving operational efficiency for healthcare providers.
AVA
Venture Round in 2018
AVA is a developer of a lightweight health device that monitors and filters pollutants. Its health device uses air quality sensors to filter small particles, which can be charged using a USB port and regulated through an application with the increasing levels of air impurities that enable users to protect themselves from specific pollutant details that can negatively affect their health.
Eva
Venture Round in 2018
Higia Technologies, founded in 2016 and based in Mexico City, specializes in developing EVA, a non-invasive wearable device aimed at assessing breast cancer risk. This innovative device features tactile sensors that map the surface of the breast and its surrounding areas. By continuously monitoring changes in breast temperature, size, and weight through embedded biosensors, EVA empowers women to actively track their breast health. The company's focus is on making breast cancer risk assessment more accessible and user-friendly.
HealthMyne
Series B in 2018
HealthMyne, Inc. is a healthcare informatics company based in Madison, Wisconsin, specializing in innovative search, analytics, and imaging solutions tailored for cancer care providers. Founded in 2013, the company aims to enhance clinical decision-making by offering real-time, evidence-based imaging insights that support optimized patient care and reduce delivery costs. HealthMyne's technology enables physicians to manipulate tumor images and access electronic health records and image repositories, facilitating the diagnosis and treatment of similar cases. The company’s platform also focuses on improving patient management through features such as automatic tumor staging, dose overlays, and specialized reporting, which streamline clinical workflows and support precision medicine initiatives.
Farcast
Series C in 2018
Farcast Biosciences, established in 2019, is a clinical diagnostic company based in Boston, Massachusetts, with operations in Bangalore, India. The company specializes in developing and utilizing a proprietary Human Tumor Micro Dynamics (HTMD) platform. This platform preserves the natural state of human tumors through the culture of fresh, unmodified tumor fragments, creating a human tumor microenvironment. Farcast's technology enables oncologists to evaluate individual tumors and predict patient response to treatments before initiating therapy. Additionally, it serves drug developers and researchers by providing accurate and precise models for testing and analysis, facilitating the development of personalized cancer therapies.
FØCAL
Venture Round in 2018
FØCAL, LLC is a company that specializes in web-based image analytics and automation solutions for developing computer vision systems. Founded in 2015 and based in Cambridge, Massachusetts, FØCAL's offerings include advanced computer vision algorithms designed to enhance workflows across various sectors, including medical diagnostics, life sciences, security, and manufacturing quality control. The company emerged from DARPA-funded research and has collaborated with leading organizations, leveraging expertise from institutions like MIT and Boston University. FØCAL's solutions serve as a foundational framework for computer vision applications in the cloud, catering to a diverse clientele ranging from startups to large enterprises.
SonderMind
Venture Round in 2018
SonderMind is a Denver-based digital health company established in 2017, specializing in accessible and approachable mental health services. It operates an online platform that connects individuals with a network of licensed therapists, offering a range of services including video telehealth and in-person sessions. SonderMind focuses on various mental health conditions such as anxiety, depression, ADHD, and PTSD, among others. The company aims to streamline the process of finding and accessing mental health care, ensuring a good match between clients and therapists, while also supporting therapists by handling administrative and billing tasks.
SHINE
Series B in 2018
SHINE develops and deploys fusion-based technology to produce medical isotopes and neutron sources. Its processes generate molybdenum-99, a precursor to technetium-99m used in diagnostic imaging, and lutetium-177 for diagnostic and therapeutic use, along with iodine-131 and iodine-125 for thyroid treatment and brachytherapy, and xenon-133 for lung and brain imaging. The company’s systems also provide neutron sources for industrial imaging, radiation-effects testing, and fusion materials research. In addition to medical isotopes, SHINE aims to recycle nuclear waste and advance fusion power as a source of clean energy. The business serves health care and industrial customers worldwide. SHINE is based in Janesville, Wisconsin, with an office in Alkmaar, Netherlands.
Accolade
Series F in 2018
Accolade, Inc. is a technology-driven company that provides personalized health and benefits solutions designed to enhance the healthcare experience for employees and their families in the United States. Founded in 2007 and headquartered in Plymouth Meeting, Pennsylvania, Accolade offers a comprehensive platform that combines cloud-based technology with support from a team of health assistants and clinicians, including nurses and behavioral health specialists. The company's services help employers navigate the complexities of the healthcare system and workplace benefits, ultimately aiming to improve health outcomes and reduce costs. By focusing on healthcare process improvement and employee engagement, Accolade delivers tailored advocacy to meet the specific needs of its clients.
DOTS
Venture Round in 2018
DOTS Technology Corp, founded in 2013 and located in Natick, Massachusetts, operates a diagnostic platform designed to assist consumers with food allergies. The company is focused on developing a food allergen detection system that allows users to test food on the spot, providing immediate information to enhance decision-making and improve the overall quality of life for individuals affected by food allergies. By advancing point-of-care detection technology, DOTS aims to address the needs of millions of consumers and has applications in both consumer and industrial sectors.
AVA
Series A in 2018
AVA is a developer of a lightweight health device that monitors and filters pollutants. Its health device uses air quality sensors to filter small particles, which can be charged using a USB port and regulated through an application with the increasing levels of air impurities that enable users to protect themselves from specific pollutant details that can negatively affect their health.
Celularity
Venture Round in 2017
Celularity is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies targeting various diseases, including cancer, infectious, and degenerative conditions.
HealthMyne
Venture Round in 2017
HealthMyne, Inc. is a healthcare informatics company based in Madison, Wisconsin, specializing in innovative search, analytics, and imaging solutions tailored for cancer care providers. Founded in 2013, the company aims to enhance clinical decision-making by offering real-time, evidence-based imaging insights that support optimized patient care and reduce delivery costs. HealthMyne's technology enables physicians to manipulate tumor images and access electronic health records and image repositories, facilitating the diagnosis and treatment of similar cases. The company’s platform also focuses on improving patient management through features such as automatic tumor staging, dose overlays, and specialized reporting, which streamline clinical workflows and support precision medicine initiatives.
Kinsa
Series B in 2017
Kinsa, Inc., established in 2012 and headquartered in San Francisco, develops smart thermometers that connect to both Android and iOS devices. These thermometers facilitate communication with individuals who are ill, providing them with care information and enabling data collection to map and track health trends in real-time, thereby aiding in disease spread prevention.
Cleared
Cleared is a telehealth company specializing in personalized care for allergy, asthma, and immunology. It operates an online clinic that allows patients to report their symptoms and medical history for evaluation and diagnosis. By leveraging this information, allergists can prescribe tailored treatment plans, ensuring that patients receive effective and individualized care from the comfort of their homes. Cleared aims to provide affordable, accessible, and convenient treatment options, making it easier for individuals to manage their allergies and related conditions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.